Lindberg C, Boréus L O, de Château P, Lindström B, Lönnerholm G, Nyberg L
Eur J Respir Dis Suppl. 1984;134:87-91.
Terbutaline has been determined in milk and plasma from 4 nursing mothers treated with Bricanyl tablets (2.5 or 5 mg, 3 times daily) because of obstructive lung disease. Both doses produced milk concentrations of terbutaline in the range 2.5-4.6 ng/mL, which were similar to or higher than the concentrations found in plasma. The highest milk:plasma concentration ratios (up to 2.9) were observed at the beginning and end of the dosage interval. The infants in this study were estimated to have ingested about 0.4-0.6 micrograms/kg/day of terbutaline base, which corresponds to 0.2-0.7% of the daily dose per kg taken by the mothers. Terbutaline was not detectable in plasma when samples were taken from one of the infants and no symptoms of beta-adrenoceptor stimulation could be found in any of the babies.
对4名因阻塞性肺病而服用间羟舒喘宁片(2.5毫克或5毫克,每日3次)的哺乳期母亲的乳汁和血浆中的特布他林进行了测定。两种剂量的特布他林在乳汁中的浓度范围为2.5 - 4.6纳克/毫升,与血浆中发现的浓度相似或更高。在给药间隔的开始和结束时观察到最高的乳汁:血浆浓度比(高达2.9)。据估计,本研究中的婴儿每天摄入约0.4 - 0.6微克/千克体重的特布他林碱,这相当于母亲每千克体重每日剂量的0.2 - 0.7%。从其中一名婴儿采集样本时,血浆中未检测到特布他林,且在任何婴儿中均未发现β-肾上腺素能受体刺激的症状。